Navigation Links
Blue Dye Test Alternative Boosts Production Yields During Tough Times
Date:9/29/2009

r blisterpacking of tablets and capsules. PakScan takes all the benefits of BlisterScan and offers them to a wider range of packaging manufacturers who require effective leak testing for pouches and sachets. Like BlisterScan it replaces the traditional blue-dye testing method of checking for leaks using a liquid test which rendered the packs and their contents un-useable regardless of whether they have a hole in them or not. PakScan identifies leaks in single or multiple non-porous sachets and pouches using a clean, dry, non-contact laser scanning method, so all samples which ‘pass’ the test can be re-introduced to the packaging line, thus reducing wastage and increasing productivity.”

In response to the intense interest in PackScan, Sepha will be at Fachpack, Nuremburg, from 29 September -1 October in Hall 1 Booth 116. They will be exhibiting alongside the production machinery manufacturer, Romaco. “We are delighted to be partnering with Romaco for Fachpack,” continues Aubrey Sayers. “It’s a great vote of confidence to have such a globally respected company as Romaco endorse our brand as part of their overall commitment to finding the most innovative and efficient solutions for packaging manufacturing.”

PakScan identifies leaks as small as 10µ in non-porous single cavity packs such as sachets, pouches, bags MAPs etc in flexible materials such as PVC, PVDC, Alu/Alu, Aclar. It simultaneously tests up to 4 packs measuring up to 250mm x 80mm x 20mm each and can also be customised for larger packs gives extremely accurate results for each individual sachet.

In addition to pharmaceutical leak testing, Sepha also designs and manufactures a range of deblistering machines for product recovery from pharmaceutical blisters and lab-scale blister p
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
2. In vivo visualization of alternative splicing
3. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
4. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
5. A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy
6. JIC Invests in Three New Alternative Energy Projects
7. Vermillion Retains ThinkPanmure to Assist in the Evaluation of Potential Strategic Alternatives
8. Alfacell Hires Advisors to Advance Strategic Alternatives
9. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
10. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
11. ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blue Dye Test Alternative Boosts Production Yields During Tough Times
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Tunnell ... joined the firm as senior statistician and Principal, a ... of experience in the management and analysis of complex ... and chemical industries. , “We’re delighted to have Julia ... in data analytics,” said Dr. Philippe Cini, Group Vice ...
(Date:5/20/2015)... May 20, 2015  Select Medical Corporation ("Select") ... Trade Commission granted early termination of the waiting ... of 1976, as amended, applicable to the acquisition ... a joint venture that Select has created with ... As previously announced, MJ Acquisition Corporation has signed ...
(Date:5/20/2015)... , May 20, 2015  Haemonetics Corporation (NYSE: ... President & CEO, will present at The Jefferies 2015 ... on June 1 st , 2015 at 8:30am ... Mr. Concannon,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... Reportlinker.com announces that a new market research ... Global Biomarkers Industry ... This report analyzes the worldwide markets ... following Technologies and Services: Technologies - Emerging ...
... cells containing a single set of chromosomes for the ... and EMBO. The technique should allow scientists to better ... Mammal cells usually contain two sets of chromosomes ... father. The genetic information contained in these chromosome sets ...
... Sept. 7, 2011 BioStorage Technologies, a global ... cold chain logistics, will host its third in ... Symposia in conjunction with the 4th annual Biorepositories ... presentations from a diverse panel of multidisciplinary professionals ...
Cached Biology Technology:Global Biomarkers Industry 2Global Biomarkers Industry 3Global Biomarkers Industry 4Global Biomarkers Industry 5Global Biomarkers Industry 6Global Biomarkers Industry 7Global Biomarkers Industry 8Global Biomarkers Industry 9Global Biomarkers Industry 10Global Biomarkers Industry 11Global Biomarkers Industry 12Global Biomarkers Industry 13Global Biomarkers Industry 14Global Biomarkers Industry 15Global Biomarkers Industry 16Global Biomarkers Industry 17Global Biomarkers Industry 18Global Biomarkers Industry 19Global Biomarkers Industry 20Global Biomarkers Industry 21Global Biomarkers Industry 22Global Biomarkers Industry 23Global Biomarkers Industry 24Global Biomarkers Industry 25Scientists create mammalian cells with single chromosome set 2BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference 2BioStorage Technologies, Inc. to Hold Global Sample Management Benchmarking Symposium in Conjunction With 2011 IIR Biorepositories Conference 3
(Date:5/18/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market, reminds investors and ... Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, ... 2015. The three-day conference is organized into ... speaking in is themed Global Fraud: Where is the ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... This release is available in Spanish . ... Exploration of the Sea) met in Bilbao from 5 to 11 ... Dory on the south platform. The meeting was coordinated by AZTI-Tecnalia ... it is held in Bilbao (previously it was held there in ...
... Singapore,s Agency for Science, Technology and Research (A*STAR), have made ... treatment. Their work, published online in the leading journal ... on how to tap on the properties of p53, the ... cells while sparing normal cells. The researchers, led by ...
... timing of umbilical cord clamping at birth should be delayed ... of South Florida,s Center of Excellence for Aging and Brain ... longer period of time allows more umbilical cord blood volume ... period extended, many good physiological "gifts" are transferred through ,nature,s ...
Cached Biology News:Meeting of ICES/CIEM experts in Bilbao on state of demersal fish populations 2Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments 2Do we clamp the umbilical cord too soon? 2Do we clamp the umbilical cord too soon? 3